The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Robert A. Kyle

Department of Medicine

Division of Hematology

Mayo Clinic

200 First Street SW

USA

[email]@mayo.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Division of Hematology, Mayo Clinic, 200 First Street SW, USA. 2007 - 2011
  • Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. 2001 - 2009
  • Division of Hematology and Internal Medicine; Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, USA. 2000 - 2005
  • Mayo Clinic, Rochester, MN 55905, USA. 2005

References

  1. History of multiple myeloma. Kyle, R.A., Steensma, D.P. Recent Results Cancer Res. (2011) [Pubmed]
  2. Treatment of multiple myeloma: a comprehensive review. Kyle, R.A., Rajkumar, S.V. Clin. Lymphoma. Myeloma (2009) [Pubmed]
  3. The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. Kyle, R.A., Jacobus, S., Friedenberg, W.R., Slabber, C.F., Rajkumar, S.V., Greipp, P.R. Cancer (2009) [Pubmed]
  4. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Kyle, R.A., Rajkumar, S.V. Leukemia (2009) [Pubmed]
  5. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia. Kyle, R.A., Benson, J., Larson, D., Therneau, T., Dispenzieri, A., Melton Iii, L.J., Rajkumar, S.V. Clinical. Lymphoma. &. Myeloma (2009) [Pubmed]
  6. Multiple myeloma. Kyle, R.A., Rajkumar, S.V. Blood (2008) [Pubmed]
  7. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. Kyle, R.A., Remstein, E.D., Therneau, T.M., Dispenzieri, A., Kurtin, P.J., Hodnefield, J.M., Larson, D.R., Plevak, M.F., Jelinek, D.F., Fonseca, R., Melton, L.J., Rajkumar, S.V. N. Engl. J. Med. (2007) [Pubmed]
  8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Kyle, R.A., Rajkumar, S.V. Hematol. Oncol. Clin. North Am. (2007) [Pubmed]
  9. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle, R.A., Rajkumar, S.V. Br. J. Haematol. (2007) [Pubmed]
  10. Epidemiology of the plasma-cell disorders. Kyle, R.A., Rajkumar, S.V. Best. Pract. Res. Clin. Haematol (2007) [Pubmed]
  11. Prevalence of monoclonal gammopathy of undetermined significance. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F., Offord, J.R., Dispenzieri, A., Katzmann, J.A., Melton, L.J. N. Engl. J. Med. (2006) [Pubmed]
  12. Monoclonal gammopathy of undetermined significance. Kyle, R.A., Rajkumar, S.V. Br. J. Haematol. (2006) [Pubmed]
  13. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Kyle, R.A., Rajkumar, S.V., Therneau, T.M., Larson, D.R., Plevak, M.F., Melton, L.J. Clin. Lymphoma (2005) [Pubmed]
  14. Five decades of therapy for multiple myeloma: a paradigm for therapeutic models. Kyle, R.A. Leukemia (2005) [Pubmed]
  15. Monoclonal gammopathies of undetermined significance. Kyle, R.A., Rajkumar, S.V. Best. Pract. Res. Clin. Haematol (2005) [Pubmed]
  16. Monoclonal gammopathy of undetermined significance. Kyle, R.A., Rajkumar, S.V. Clinical. Lymphoma. &. Myeloma (2005) [Pubmed]
  17. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F., Melton, L.J. Mayo Clin. Proc. (2004) [Pubmed]
  18. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F., Melton, L.J. Cancer (2004) [Pubmed]
  19. Multiple myeloma. Kyle, R.A., Rajkumar, S.V. N. Engl. J. Med. (2004) [Pubmed]
  20. Review of 1027 patients with newly diagnosed multiple myeloma. Kyle, R.A., Gertz, M.A., Witzig, T.E., Lust, J.A., Lacy, M.Q., Dispenzieri, A., Fonseca, R., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.E., Therneau, T.M., Greipp, P.R. Mayo Clin. Proc. (2003) [Pubmed]
  21. Monoclonal gammopathies of undetermined significance: a review. Kyle, R.A., Rajkumar, S.V. Immunol. Rev. (2003) [Pubmed]
  22. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Remstein, E.D., Offord, J.R., Larson, D.R., Plevak, M.F., Melton, L.J. Blood (2003) [Pubmed]
  23. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F., Melton, L.J. N. Engl. J. Med. (2002) [Pubmed]
  24. Monoclonal gammopathies of undetermined significance. Kyle, R.A., Rajkumar, S.V. Rev. Clin. Exp. Hematol (2002) [Pubmed]
  25. Update on the treatment of multiple myeloma. Kyle, R.A. Oncologist (2001) [Pubmed]
  26. Amyloidosis: a convoluted story. Kyle, R.A. Br. J. Haematol. (2001) [Pubmed]
  27. Management of patients with multiple myeloma: emphasizing the role of high-dose therapy. Kyle, R.A. Clin. Lymphoma (2001) [Pubmed]
  28. Henry Bence Jones--physician, chemist, scientist and biographer: a man for all seasons. Kyle, R.A. Br. J. Haematol. (2001) [Pubmed]
  29. Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. Kyle, R.A., Greipp, P.R., Gertz, M.A., Witzig, T.E., Lust, J.A., Lacy, M.Q., Therneau, T.M. Br. J. Haematol. (2000) [Pubmed]
  30. Multiple myeloma: an odyssey of discovery. Kyle, R.A. Br. J. Haematol. (2000) [Pubmed]
 
WikiGenes - Universities